VEXAS Syndrome and Substance Use Disorders: A Large‐Scale, Propensity‐Matched, Case‐Control Analysis Revealing Immune‐Mediated Comorbidities
Open Access
- 6 July 2025
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (3) , 584-586
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registryRheumatology, 2024
- VEXAS syndromeInternational Journal of Hematology, 2024
- VEXAS Syndrome—ReviewGlobal Medical Genetics, 2023
- An update on VEXAS syndromeExpert Review of Clinical Immunology, 2022
- C-reactive protein and substance use disorders in adolescence and early adulthood: A prospective analysisDrug and Alcohol Dependence, 2013